Ortensia Vito
AstraZeneca BioPharmaceuticals R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Histological and clinical phenotypes of diabetic kidney disease: a baseline analysis of the HEROIC study.
Journal: Clinical kidney journal
Published: March 18, 2026
Cardiovascular-kidney-metabolic syndrome: prevalence, risks, disease trajectories, and early-stage management.
Journal: American journal of physiology. Cell physiology
Published: November 21, 2025
Novel RNA biomarkers improve discrimination of children with tuberculosis disease from those with non-TB pneumonia after in vitro stimulation.
Journal: Frontiers in immunology
Published: March 15, 2024
A computational framework to improve cross-platform implementation of transcriptomics signatures.
Journal: EBioMedicine
Published: January 10, 2024
Integration and validation of host transcript signatures, including a novel 3-transcript tuberculosis signature, to enable one-step multiclass diagnosis of childhood febrile disease.
Journal: Journal of translational medicine
Published: January 09, 2024
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study.
Journal: The Lancet. Rheumatology
Published: March 01, 2023
Diagnosis of Multisystem Inflammatory Syndrome in Children by a Whole-Blood Transcriptional Signature.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: November 09, 2022
Transcriptomics for child and adolescent tuberculosis.
Journal: Immunological reviews
Published: July 12, 2022
Characterisation of the blood RNA host response underpinning severity in COVID-19 patients.
Journal: Scientific reports
Published: October 26, 2021
Treatment of Multisystem Inflammatory Syndrome in Children.
Journal: The New England journal of medicine
Published: June 16, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026